Atopic dermatitis (eczema): open trials in South Korea

• NCT06947993

  Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  Trial Treatment · Phase 2 · Novartis Pharmaceuticals

  Ansan · Seoul

  Registry updated 2026-09-28

All Atopic dermatitis (eczema) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error